AU8317901A - Methods for modulating multiple lineage kinase proteins and screening compounds which modulate multiple linease kinase proteins - Google Patents
Methods for modulating multiple lineage kinase proteins and screening compounds which modulate multiple linease kinase proteinsInfo
- Publication number
- AU8317901A AU8317901A AU8317901A AU8317901A AU8317901A AU 8317901 A AU8317901 A AU 8317901A AU 8317901 A AU8317901 A AU 8317901A AU 8317901 A AU8317901 A AU 8317901A AU 8317901 A AU8317901 A AU 8317901A
- Authority
- AU
- Australia
- Prior art keywords
- kinase proteins
- linease
- methods
- screening compounds
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 2
- 102000020233 phosphotransferase Human genes 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63705400A | 2000-08-11 | 2000-08-11 | |
PCT/US2001/024822 WO2002014536A2 (en) | 2000-08-11 | 2001-08-08 | Odulating multiple lineage kinase proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8317901A true AU8317901A (en) | 2002-02-25 |
Family
ID=24554347
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU8317901A Pending AU8317901A (en) | 2000-08-11 | 2001-08-08 | Methods for modulating multiple lineage kinase proteins and screening compounds which modulate multiple linease kinase proteins |
AU2001283179A Ceased AU2001283179B2 (en) | 2000-08-11 | 2001-08-08 | Modulating multiple lineage kinase proteins |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001283179A Ceased AU2001283179B2 (en) | 2000-08-11 | 2001-08-08 | Modulating multiple lineage kinase proteins |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1309721A2 (en) |
JP (1) | JP2005503102A (en) |
CN (1) | CN1458979A (en) |
AU (2) | AU8317901A (en) |
BG (1) | BG107623A (en) |
BR (1) | BR0113266A (en) |
CA (1) | CA2419985A1 (en) |
CZ (1) | CZ2003680A3 (en) |
HR (1) | HRP20030162A2 (en) |
HU (1) | HUP0501110A3 (en) |
IL (1) | IL154311A0 (en) |
IS (1) | IS6711A (en) |
MX (1) | MXPA03001218A (en) |
NO (1) | NO20030658L (en) |
NZ (1) | NZ524034A (en) |
PL (1) | PL366248A1 (en) |
SK (1) | SK2692003A3 (en) |
WO (1) | WO2002014536A2 (en) |
ZA (1) | ZA200301109B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
EP1646372A2 (en) * | 2003-07-14 | 2006-04-19 | Decode Genetics EHF. | Methods of diagnosis and treatment for asthma based on haplotype association |
US20060014165A1 (en) * | 2003-07-14 | 2006-01-19 | Decode Genetics Ehf. | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association |
US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
WO2014172616A2 (en) * | 2013-04-18 | 2014-10-23 | President And Fellows Of Harvard College | Methods, compositions and kits for promoting motor neuron survival and treating and diagnosing neurodegenerative disorders |
JP6663509B2 (en) * | 2016-11-25 | 2020-03-11 | ジェヌーヴ インク. | Composition for promoting and protecting differentiation of neural stem cells, and method for inducing nerve regeneration using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
TR200400635T2 (en) * | 1998-08-26 | 2005-10-21 | Cephalon, Inc. | Modulation of multi-generation kinase proteins |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
-
2001
- 2001-08-08 MX MXPA03001218A patent/MXPA03001218A/en not_active Application Discontinuation
- 2001-08-08 BR BR0113266-0A patent/BR0113266A/en not_active IP Right Cessation
- 2001-08-08 EP EP01961958A patent/EP1309721A2/en not_active Withdrawn
- 2001-08-08 CA CA002419985A patent/CA2419985A1/en not_active Abandoned
- 2001-08-08 JP JP2002519661A patent/JP2005503102A/en active Pending
- 2001-08-08 AU AU8317901A patent/AU8317901A/en active Pending
- 2001-08-08 CZ CZ2003680A patent/CZ2003680A3/en unknown
- 2001-08-08 CN CN01814001A patent/CN1458979A/en active Pending
- 2001-08-08 SK SK269-2003A patent/SK2692003A3/en not_active Application Discontinuation
- 2001-08-08 WO PCT/US2001/024822 patent/WO2002014536A2/en active Application Filing
- 2001-08-08 IL IL15431101A patent/IL154311A0/en unknown
- 2001-08-08 NZ NZ524034A patent/NZ524034A/en unknown
- 2001-08-08 PL PL01366248A patent/PL366248A1/en not_active Application Discontinuation
- 2001-08-08 HU HU0501110A patent/HUP0501110A3/en unknown
- 2001-08-08 AU AU2001283179A patent/AU2001283179B2/en not_active Ceased
-
2003
- 2003-02-10 NO NO20030658A patent/NO20030658L/en not_active Application Discontinuation
- 2003-02-10 ZA ZA200301109A patent/ZA200301109B/en unknown
- 2003-02-10 IS IS6711A patent/IS6711A/en unknown
- 2003-03-06 HR HR20030162A patent/HRP20030162A2/en not_active Application Discontinuation
- 2003-03-10 BG BG107623A patent/BG107623A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1309721A2 (en) | 2003-05-14 |
HUP0501110A3 (en) | 2006-06-28 |
ZA200301109B (en) | 2004-07-20 |
HRP20030162A2 (en) | 2005-12-31 |
BR0113266A (en) | 2005-01-04 |
NZ524034A (en) | 2006-11-30 |
WO2002014536A2 (en) | 2002-02-21 |
CZ2003680A3 (en) | 2003-11-12 |
JP2005503102A (en) | 2005-02-03 |
WO2002014536A3 (en) | 2003-01-30 |
MXPA03001218A (en) | 2003-05-27 |
IS6711A (en) | 2003-02-10 |
HUP0501110A2 (en) | 2006-03-28 |
WO2002014536A9 (en) | 2003-12-18 |
SK2692003A3 (en) | 2003-08-05 |
IL154311A0 (en) | 2003-09-17 |
CA2419985A1 (en) | 2002-02-21 |
NO20030658L (en) | 2003-04-09 |
BG107623A (en) | 2003-11-28 |
AU2001283179B2 (en) | 2006-07-13 |
PL366248A1 (en) | 2005-01-24 |
CN1458979A (en) | 2003-11-26 |
NO20030658D0 (en) | 2003-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5468499A (en) | 3-methylidenyl-2-indolinone modulators of protein kinase | |
IL135109A0 (en) | Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function | |
AU6411698A (en) | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | |
HUP0100302A3 (en) | Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds | |
IL141866A0 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
PL344477A1 (en) | Pyrrole substituted 2-indolinone protein kinase inhibitors | |
AU1371999A (en) | Benzothiazole protein tyrosine kinase inhibitors | |
AU7282998A (en) | Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds | |
AU3363599A (en) | Heterocyclic families of compounds for the modulation of tyrosine protein kinase | |
AU3857000A (en) | Atm kinase modulation for screening and therapies | |
DE69840203D1 (en) | Procedures for data compression | |
HUP0103079A3 (en) | Modulating multiple lineage kinase proteins | |
AU6882598A (en) | Protein kinase inhibitor | |
AU2576501A (en) | Protein kinase inhibitors | |
AU2001226387A1 (en) | Methods of identifying modulators of the fgf receptor | |
AU2002364610A8 (en) | Methods and materials for modulating trpc4 | |
AU8317901A (en) | Methods for modulating multiple lineage kinase proteins and screening compounds which modulate multiple linease kinase proteins | |
AU2591299A (en) | Human protein kinase c inhibitor | |
AU2002246912A1 (en) | Receptor-binding compounds and methods for identifying them | |
AU2002364612A1 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA | |
AU4684099A (en) | Oligonucleotides for enhanced modulation of protein kinase expression | |
IL140969A0 (en) | Methods of identification of modulators of protein function | |
GB9803399D0 (en) | Protein kinase c | |
GB0022333D0 (en) | Methods for identifying modulators of protein interactions | |
AU3097299A (en) | Nek1-related protein kinase |